PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 23, 2019Molecular Nutrition & Food Research28 citations

Protein‐Bound β‐glucan from Coriolus Versicolor has Potential for Use Against Obesity

View Full Paper
XLXiaojun LiPCPeng ChenPZPeng Zhang

Key Points

Key points are not available for this paper at this time.

Abstract

SCOPE: The prevalence of obesity and related disorders has vastly increased throughout the world and prevention of such circumstances thus represents a major challenge. Here, it has been shown that one protein-bound β-glucan (PBG) from the edible mushroom Coriolus versicolor can be a potent anti-obesity component. METHODS AND RESULTS: PBG can reduce obesity and metabolic inflammation in mice fed with a high-fat diet (HFD). Gut microbiota analysis reveals that PBG markedly increases the abundance of Akkermansia muciniphila, although it does not rescue HFD-induced change in the Firmicutes to Bacteroidetes ratio. It appears that PBG alters host physiology and creates an intestinal microenvironment favorable for A. muciniphila colonization. Fecal transplants from PBG-treated animals in part reduce obesity in recipient HFD-fed mice. Further, PBG is shown to upregulate expression of a set of genes related to host metabolism in microbiota-depleted mice. CONCLUSION: The data highlight that PBG may exert its anti-obesity effects through a mirobiota-dependent (richness of specific microbiota) and -independent (modulation of host metabolism) manner. The fact that C. versicolor PBGs are approved oral immune boosters in cancers and chronic hepatitis with well-established safety profiles may accelerate PBG as a novel use for obesity treatment.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Li et al. (2019) studied this question.

synapsesocial.com/papers/6a7d2c9ad3686d25b46e4e28https://doi.org/10.1002/mnfr.201801231
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Current pharmacotherapy for obesity2017 · 419 citations
  2. 2Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production2003 · 294 citations
  3. 3Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator–Activated Receptor α2016 · 123 citations
  4. 4Management of obesity: improvement of health-care training and systems for prevention and care2015 · 436 citations
  5. 5The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes2011 · 435 citations